Dr. Timothy S. Siegel

Erik Weise is an Urologist in Centerville, Ohio. Dr. Weise is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Congenital Mesoblastic Nephroma, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, Reconstructive Urology Surgery, and Nephrectomy. Dr. Weise is currently accepting new patients.

Jason Sprunger is an Urologist in Indianapolis, Indiana. Dr. Sprunger is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Ureterocele, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Reconstructive Urology Surgery, and Nephrectomy. Dr. Sprunger is currently accepting new patients.

Alberto Martini is an Assistant Professor and the Director of Research in the Department of Urology.He is extensively trained in robotic and laparoscopic surgery, having been mentored by pioneers in minimally invasive surgery. His professional experience spans the USA (New York City and Houston), Europe (Florence, Milan, Dresden, Prague, and Toulouse), and Australia (Melbourne). He also received specialized training in gene therapy for bladder cancer under Dr. Dinney, a gene therapy pioneer for bladder cancer, at MD Anderson Cancer Center. Dr. Martini is passionate about advancing research and utilizing innovative statistical methods to enhance healthcare approaches and patient outcomes. He has authored over 200 research articles and earned national and international recognition for his work. Notably, he holds a patent for the integration of 3D models during robotic prostatectomy, reflecting his commitment to improving surgical precision and patient care. His clinical and research focus is on urological oncology, specifically prostate, bladder, and kidney cancer.Dr. Martini actively contributes to several international working groups, including the European Association of Urology (EAU) – Young Academic Urologists group on Prostate Cancer. He is also an associate member of the scientific working group of the Robotic Urology Section of the EAU and the EAU Guidelines on muscle-invasive and metastatic bladder cancer. Dr. Martini is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Upper Tract Urothelial Carcinoma (UTUC), Prostatectomy, and Nephrectomy.